ED 1612
Alternative Names: ED-1612Latest Information Update: 17 Aug 2007
At a glance
- Originator Sosei R&D
- Class Analgesics
- Mechanism of Action Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 30 Aug 2005 Arakis has been acquired by Sosei
- 04 Dec 2003 Clinical trials in Pain in United Kingdom (PO)